Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intracerebral hemorrhage.

Neeraj Badjatia1, Jonathan Rosand

  • 1Neurocritical Care and Acute Stroke Service, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. nbadjatia@neuro.columbia.edu

The Neurologist
|November 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Leucocyte Telomere Length With Stroke, Dementia, and Late-Life Depression: The Role of Modifiable Risk Factors.

Neurology·2025
Same author

Associations Between Trust in Healthcare Professionals and Perceptions of Modifiability of Dementia and Stroke Risks Through Maintaining or Changing Lifestyle Habits.

American journal of health promotion : AJHP·2025
Same author

Harvard Electroencephalography Database: A comprehensive clinical electroencephalographic resource from four Boston hospitals.

Epilepsia·2025
Same author

The Brain Care Score and its associations with cardiovascular disease and cancer.

Family practice·2025
Same author

The Harvard-Emory ECG Database.

medRxiv : the preprint server for health sciences·2025
Same author

Use of the Brain Care Score to Estimate the Risk of Incident Cerebrovascular Events in Middle-Aged Women.

Neurology·2025
Same journal

Artificial Intelligence in the Prehospital Stage of Stroke: Can Virtual Assistants Optimize Triage?

The neurologist·2026
Same journal

Looking Beyond the Midline: An Uncommon Etiology of Internuclear Ophthalmoplegia of Abduction Due to Cerebral Venous Thrombosis.

The neurologist·2026
Same journal

Commentary: Cervical Artery Dissection and Chiropractic Cervical Manipulation: Clarifying Association, Mechanism, and Interpretation.

The neurologist·2026
Same journal

Acute Spinal Cord Infarct Secondary to Fibrocartilaginous Embolism Treated With Tenecteplase.

The neurologist·2026
Same journal

Cervical Artery Dissection and Chiropractic​​​​​.

The neurologist·2026
Same journal

Oromandibular Dyskinesia Associated With Levofloxacin and Responsive to Low-Dose Oral Diazepam: A Case Report.

The neurologist·2026
See all related articles

Intracerebral hemorrhage (ICH), a type of stroke, has high mortality. Management focuses on reducing hematoma expansion and secondary brain injury, with new treatments on the horizon.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Stroke Research

Background:

  • Intracerebral hemorrhage (ICH) is a significant cause of stroke, accounting for 10% of cases in the US.
  • ICH results from the rupture of small brain vessels, leading to high morbidity and mortality.
  • Chronic hypertension and cerebral amyloid angiopathy are primary causes, with other factors including vascular malformations and anticoagulant use.

Purpose of the Study:

  • To review the clinical course and management strategies for intracerebral hemorrhage.
  • To highlight current understanding and remaining questions regarding ICH.
  • To discuss acute and future therapeutic approaches for ICH.

Main Methods:

  • Review of existing literature on intracerebral hemorrhage.

Related Experiment Videos

  • Analysis of common risk factors and predisposing conditions.
  • Discussion of current and emerging management principles.

    • Main Results:

    • ICH management prioritizes reducing hematoma expansion in the acute phase.
    • Controlling hemostasis, hemodynamics, and intracranial pressure is crucial for minimizing secondary brain injury.
    • Despite advances, effective specific therapies for ICH are still under development, with agents like recombinant Factor VIIa showing promise.

    Conclusions:

    • Morbidity and mortality associated with ICH remain high.
    • Further research into the mechanisms of ICH, including site predilection and hemorrhage timing, is needed.
    • Novel preventive and acute treatment therapies are essential and may become available in the future.